Sign in

CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company

Silence Therapeutics plc

Sign in to watch
Tickers
SLN SLNCF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
operating
Phone
44-0-20-3457 6900
Business address
12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP

Securities

  • SLN American Depository Share Nasdaq
  • SLNCF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-03-27 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +50,000 9,611,299
2025-03-05 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +22,632 9,561,299
2025-02-18 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +60,000 9,538,667
2025-02-13 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +92,774 9,418,667
2025-02-13 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +60,000 9,478,667
2025-01-23 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +12,226 9,325,893
2025-01-21 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +25,000 9,293,667
2025-01-21 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +20,000 9,313,667
2025-01-17 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +150,000 9,268,667
2025-01-08 Griffiths Richard Ian 10% owner Purchase · American Depositary Shares +30,000 9,118,667
2025-01-02 Davidson Michael H. Director Grant or award · Share Option (Right to Buy) +48,000 48,000
2025-01-02 Ede-Golightly James Director Grant or award · Share Option (Right to Buy) +48,000 48,000
2025-01-02 Ross Iain Director Grant or award · Share Option (Right to Buy) +90,000 90,000
2025-01-02 Lemus David Director Grant or award · Share Option (Right to Buy) +48,000 48,000
2025-01-02 Romano Steven J. EVP and Chief R&D Officer Grant or award · Employee Share Option (Right to Buy) +285,000 285,000
2025-01-02 HELLUMS RHONDA LYNETTE Chief Financial Officer Grant or award · Employee Share Option (Right to Buy) +375,000 375,000
2025-01-02 TOOMAN CRAIG A President and CEO Grant or award · Employee Share Option (Right to Buy) +900,000 900,000

Page 5 of 5 · 97 trades